| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_feb75f0e8bcd960158c6c1aa59832ef1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383 |
| filingDate |
2019-01-17^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-04-27^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccaa1b79a571c33df34007ec791a28c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0659f983e3fd2d06bd9355eb128e5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eed5b95a2cec898c5611772bc690d88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58395de14d7ea14853c7fd3570b26e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5e2e19bea37cc8131c63eaf46b4ac1 |
| publicationDate |
2021-04-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10987357-B2 |
| titleOfInvention |
Aerosolized fluoroquinolones and uses thereof |
| abstract |
Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022047604-A1 |
| priorityDate |
2005-05-18^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |